SG Americas Securities
XERS icon

SG Americas Securities’s Xeris Biopharma Holdings XERS Stock Holding History

SG Americas Securities’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
13,713
-108,198
-89% -$691K ﹤0.01% 3080
2026
Q1 		$707K Buy
121,911
+11,731
+11% +$77.8K ﹤0.01% 1979
2025
Q4 		$865K Buy
110,180
+26,966
+32% +$212K ﹤0.01% 2132
2025
Q3 		$677K Buy
83,214
+63,921
+331% +$425K ﹤0.01% 1844
2025
Q2 		$90K Sell
19,293
-51,206
-73% -$235K ﹤0.01% 2659
2025
Q1 		$387K Sell
70,499
-24,172
-26% -$97.6K ﹤0.01% 1991
2024
Q4 		$321K Buy
94,671
+34,469
+57% +$111K ﹤0.01% 1735
2024
Q3 		$172K Buy
60,202
+39,335
+189% +$101K ﹤0.01% 2617
2024
Q2 		$47K Sell
20,867
-150
-0.7% -$302 ﹤0.01% 2685
2024
Q1 		$46K Sell
21,017
-12,760
-38% -$33K ﹤0.01% 2782
2023
Q4 		$79K Buy
33,777
+15,414
+84% +$28.4K ﹤0.01% 2836
2023
Q3 		$34K Buy
+18,363
New +$42.1K ﹤0.01% 2998
2023
Q2 		– Sell
-40,947
Closed -$67K – 3263
2023
Q1 		$67K Buy
+40,947
New +$51.3K ﹤0.01% 3018
2022
Q4 		– Sell
-25,397
Closed -$40K – 3423
2022
Q3 		$40K Buy
+25,397
New +$42K ﹤0.01% 3028
2021
Q3 		– Sell
-244,228
Closed -$994K – 3914
2021
Q2 		$994K Buy
+244,228
New +$932K ﹤0.01% 1559
2020
Q3 		– Sell
-20,438
Closed -$54K – 3536
2020
Q2 		$54K Buy
20,438
+7,215
+55% +$25.1K ﹤0.01% 3520
2020
Q1 		$26K Buy
+13,223
New +$56.9K ﹤0.01% 3275

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SG Americas Securities's XERS Position: Q2 2026 in Review

SG Americas Securities reduced its Xeris Biopharma Holdings (XERS) stake by 89% in Q2 2026, selling an estimated $691K and leaving 13,713 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3080.

SG Americas Securities first reported a position in XERS in Q1 2020 and has held it in 17 quarters since. The position peaked at $994K in Q2 2021. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • SG Americas Securities held 13,713 shares of Xeris Biopharma Holdings worth $109K as of Q2 2026.
  • SG Americas Securities sold 108,198 Xeris Biopharma Holdings shares in Q2 2026, an estimated $691K.
  • Xeris Biopharma Holdings made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3080 holding.
  • SG Americas Securities first reported a position in Xeris Biopharma Holdings in Q1 2020 and has held it in 17 quarters since.
  • SG Americas Securities's Xeris Biopharma Holdings position peaked at $994K in Q2 2021.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.